Efficacy of Red Light in the Treatment of Pigmentary Disorders

Vitiligo Clinical Trial

Official title: A Prospective, Double-blind, Split-body, Randomized Controlled Trial to Assess the Efficacy of Low Level Laser Therapy for Pigmentary Disorders

Status Recruiting

Clinical Trial Summary

Pigmentary disorders such as melasma, lichen planus pigmentosus and vitiligo can significantly affect patients' quality of life. Treatment responses are usually slow and typically have limited efficacy. In recent years, low level laser therapy has been an emerging treatment modality for androgenetic alopecia, acne, wound healing and photorejuvenation. This is a prospective, double-blind, split-body, randomized controlled trial assessing the efficacy of low level laser therapy with red light for pigmentary disorders such as, melasma, lichen planus pigmentosus and vitiligo.

Clinical Trial Description

This will be a participant and evaluator blinded trial with random allocation of one side of the face or affected area to treatment and the contralateral side as control. Random allocation of the treatment side will be performed using randomization software. Participants will be treated twice a week for 12 weeks with low irradiation 650 nm +/- 5 nm red light and followed up 4 weeks after completion of treatment. A trained blinded evaluator will assess clinical outcomes on week 4, week 8, week 12 and at follow up at week 16, using validated scores. ;

Related Conditions & MeSH terms

• Lichen Planus
• Lichen Planus Pigmentosus
• Melanosis
• Melasma
• Vitiligo

• NCT number: NCT04308421
• Study type: Interventional
• Source: University of British Columbia
• Contact: Sunil Kalia, MD MHSc FRCPC
• Phone: +1 604-875-4747
• Email: sunil.kalia@ubc.ca
• Status: Recruiting
• Phase: N/A
• Start date: March 1, 2020
• Completion date: September 2020